In addition, CD7+ cell lines and primary AML blasts from R/R-AML patients in vitro and CD7+AML xenograft models were used to assess the antileukaemic ability of naturally selected CD7 CAR-T cells, demonstrating powerful cytotoxic effects on CD7+ AML cells. The gene discussed is CD7; the disease is acute myeloid leukemia.